Paper36980324
IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers.
Haslund-Gourley BS and 2 others. Diagnostics (Basel), 2023. Cited by 27 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers. Papers, record 36980324. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980324
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References139
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,004,930 | Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. | Mol Cell Proteomics | 2014 | https://conductscience.org/library/papers/25004930 | PubMed |
| 2 | 30,306,206 | A review of inflammatory mechanism in airway diseases. | Inflamm Res | 2019 | https://conductscience.org/library/papers/30306206 | PubMed |
| 3 | 24,533,874 | IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins. | J Proteome Res | 2014 | https://conductscience.org/library/papers/24533874 | PubMed |
| 4 | 30,723,033 | Higher order thinking about differential diagnosis. | Braz J Phys Ther | 2020 | https://conductscience.org/library/papers/30723033 | PubMed |
| 5 | 32,060,529 | Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis. | J Infect Dis | 2020 | https://conductscience.org/library/papers/32060529 | PubMed |
| 6 | 30,622,446 | High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation. | Clin Proteomics | 2019 | https://conductscience.org/library/papers/30622446 | PubMed |
| 7 | 34,487,783 | A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer. | Gastroenterology | 2021 | https://conductscience.org/library/papers/34487783 | PubMed |
| 8 | 28,169,190 | Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis. | EBioMedicine | 2017 | https://conductscience.org/library/papers/28169190 | PubMed |
| 9 | 33,979,301 | High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33979301 | PubMed |
| 10 | 31,814,749 | The Association Between Normal BMI With Central Adiposity And Proinflammatory Potential Immunoglobulin G N-Glycosylation. | Diabetes Metab Syndr Obes | 2019 | https://conductscience.org/library/papers/31814749 | PubMed |
| 11 | 36,121,650 | Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer. | Int J Cancer | 2023 | https://conductscience.org/library/papers/36121650 | PubMed |
| 12 | 31,936,666 | 3D Structure and Function of Glycosyltransferases Involved in N-glycan Maturation. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31936666 | PubMed |
| 13 | 29,903,548 | Antibody glycosylation in inflammation, disease and vaccination. | Semin Immunol | 2018 | https://conductscience.org/library/papers/29903548 | PubMed |
| 14 | 36,140,772 | Large-Scale Sequencing of Borreliaceae for the Construction of Pan-Genomic-Based Diagnostics. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36140772 | PubMed |
| 15 | 34,630,427 | Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study. | Front Immunol | 2021 | https://conductscience.org/library/papers/34630427 | PubMed |
| 16 | 23,382,691 | Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. | PLoS Genet | 2013 | https://conductscience.org/library/papers/23382691 | PubMed |
| 17 | 26,436,649 | Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26436649 | PubMed |
| 18 | 16,055,342 | Dynamics of colorectal cancer. | Semin Cancer Biol | 2005 | https://conductscience.org/library/papers/16055342 | PubMed |
| 19 | 34,942,102 | Diagnostics for COVID-19: moving from pandemic response to control. | Lancet | 2022 | https://conductscience.org/library/papers/34942102 | PubMed |
| 20 | 27,482,182 | Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West. | Gastroenterol Hepatol (N Y) | 2015 | https://conductscience.org/library/papers/27482182 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,941,806 | From Prediction to Generation: Artificial Intelligence Reconstructing the Paradigm of Protein Glycosylation Research. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941806 | PubMed |
| 42,382,990 | Glycosylation profile of Mycobacterium leprae-specific antibodies associated with disseminated infection. | iScience | 2026 | https://conductscience.org/library/papers/42382990 | PubMed |
| 42,250,139 | Comparative evaluation of different MALDI-TOF-MS platforms for plasma IgG N-glycan profiling: impact on analytical performance and clinical conclusions. | Anal Bioanal Chem | 2026 | https://conductscience.org/library/papers/42250139 | PubMed |
| 41,965,542 | Epidemiology, diagnosis and emerging therapies for Lyme disease of the Northern Hemisphere. | Int J Emerg Med | 2026 | https://conductscience.org/library/papers/41965542 | PubMed |
| 41,727,429 | Immunoglobulin G N-glycosylation remodeling in viral infections: immunomodulatory roles and potential biomarker implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/41727429 | PubMed |
| 41,387,437 | Asymmetrically glycosylated IgG1 antibodies are universal and drive human disease. | Nat Commun | 2025 | https://conductscience.org/library/papers/41387437 | PubMed |
| 41,373,650 | Quantitative Modeling of IgG N-Glycosylation Profiles from Population Data. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373650 | PubMed |
| 41,310,581 | Therapy-induced remodeling of IgG and plasma N-glycans in breast cancer. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41310581 | PubMed |
| 41,012,654 | Fc-Mediated Effector Functions of Anti-NS1 Antibodies in Dengue. | Viruses | 2025 | https://conductscience.org/library/papers/41012654 | PubMed |
| 40,948,983 | Establishment of reference intervals for serum immunoglobulin G N-glycosylation features in healthy Chinese adults: a nationwide survey in the framework of predictive, preventive, and personalized medicine. | EPMA J | 2025 | https://conductscience.org/library/papers/40948983 | PubMed |
| 40,672,940 | Identification and validation of glycosylation-related gene signatures for prognostic stratification in sepsis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40672940 | PubMed |
| 40,165,956 | Immunoglobulin G N-Glycome as a biomarker of mortality risk in Escherichia coli induced sepsis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40165956 | PubMed |
| 39,634,222 | Human IgG Subclasses Differ in the Structural Elements of Their N-Glycosylation. | ACS Cent Sci | 2024 | https://conductscience.org/library/papers/39634222 | PubMed |
| 39,543,382 | High-throughput glycosaminoglycan extraction and UHPLC-MS/MS quantification in human biofluids. | Nat Protoc | 2025 | https://conductscience.org/library/papers/39543382 | PubMed |
| 39,126,246 | Immunoglobulin G glycosylation and its alterations in aging-related diseases. | Acta Biochim Biophys Sin (Shanghai) | 2024 | https://conductscience.org/library/papers/39126246 | PubMed |
| 38,952,341 | Glyco-signatures in patients with advanced lung cancer during anti-PD-1/PD-L1 immunotherapy. | Acta Biochim Biophys Sin (Shanghai) | 2024 | https://conductscience.org/library/papers/38952341 | PubMed |
| 38,785,919 | The Exploitation of the Glycosylation Pattern in Asthma: How We Alter Ancestral Pathways to Develop New Treatments. | Biomolecules | 2024 | https://conductscience.org/library/papers/38785919 | PubMed |
| 38,600,088 | Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection. | Nat Commun | 2024 | https://conductscience.org/library/papers/38600088 | PubMed |
| 38,572,072 | The association between plasma IgG N-glycosylation and neonatal hypoxic-ischemic encephalopathy: a case-control study. | Front Cell Neurosci | 2024 | https://conductscience.org/library/papers/38572072 | PubMed |
| 38,248,857 | Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review. | Metabolites | 2024 | https://conductscience.org/library/papers/38248857 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980324
GET https://conductscience.org/api/papers/v1/36980324/references?page=2